| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Feb 4, 2025 | Atea Pharmaceuticals, Inc. | CEO | Sell | 62.5 | +10,916 | 0.18% | ✗ | $271.1K |
| Sep 17, 2024 | Sep 19, 2024 | Atea Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -57,969 | -0.96% | ✓ | $234.2K |
| Jun 5, 2024 | Jun 7, 2024 | Atea Pharmaceuticals, Inc. | CEO | Sell | 52.5 | -1,006 | -0.02% | ✗ | $4K |
| Jan 31, 2024 | Feb 2, 2024 | Atea Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -56,910 | -0.93% | ✓ | $218.8K |